Introducing the new AltIndexLearn more
-$560M
Net insider buying / selling at Lifestance Health (LFST) over the last 2 years. Updated May 14, 2026

Are Lifestance Health Insiders Buying or Selling?

Lifestance Health (LFST) has had 10 insider transactions in the past 90 days, all sells. The most recent was JAMES COULTER, who sold 28,281,943 shares at $8.02 on May 12, 2026.

Insider trading patterns can signal confidence or concern from the people who know the company best. AltIndex tracks insider transactions as one of 25+ alternative data signals in the LFST AI Score. For government officials trading this stock, see LFST congressional trading.

Who’s Trading Lifestance Health Stock?

InsiderActivityTradesLast Trade
JAMES COULTER Sold $372M 2 May 12, 2026
DARREN BLACK Sold $120M 3 May 12, 2026
SUMMIT PARTNERS L P Sold $43M 1 Aug 18, 2025
Silversmith Capital Partners I-B, L.P. Sold $18M 1 Aug 18, 2025
Robert Bessler Sold $4.2M 17 May 12, 2026
Eric Shuey Sold $2M 1 May 12, 2026

Recent Lifestance Health Insider Transactions

Insider Transaction Date Type Shares Price Value
JAMES COULTERMay 12, 2026Sell28,281,943$8.02$227M
DARREN BLACKMay 12, 2026Sell5,899,661$8.02$47M
Robert BesslerMay 12, 2026Sell287,517$8.02$2.3M
Eric ShueyMay 12, 2026Sell243,362$8.02$2M
Robert BesslerMay 7, 2026Sell37,500$8.55$320,000
Robert BesslerApr 24, 2026Sell31,074$7.05$220,000
Robert BesslerApr 24, 2026Sell31,073$7.05$220,000
Robert BesslerApr 23, 2026Sell3,876$7$27,000
Robert BesslerApr 21, 2026Sell2,551$7.01$18,000
Robert BesslerApr 21, 2026Sell2,550$7.01$18,000
JAMES COULTERMar 2, 2026Sell20,685,061$7.01$145M
DARREN BLACKMar 2, 2026Sell4,314,939$7.01$30M
Robert BesslerDec 22, 2025Sell851$7.04$6,000
Robert BesslerDec 22, 2025Sell850$7.04$6,000
Robert BesslerDec 19, 2025Sell59,971$7.04$420,000
Robert BesslerDec 18, 2025Sell3,221$7$23,000
Ann VaranakisDec 17, 2025Sell50,000$6.9$350,000
Robert BesslerDec 15, 2025Sell6,186$7$43,000
Robert BesslerDec 15, 2025Sell6,185$7$43,000
Robert BesslerDec 12, 2025Sell39,815$7.01$280,000
Lisa MillerNov 21, 2025Sell57,240$6.43$370,000
SUMMIT PARTNERS L PAug 18, 2025Sell8,407,643$5.07$43M
Silversmith Capital Partners I-B, L.P.Aug 18, 2025Sell3,592,357$5.07$18M
DARREN BLACKAug 18, 2025Sell8,407,643$5.07$43M
Kenneth BurdickAug 11, 2025Buy18,660$4.54$85,000
Kenneth BurdickAug 11, 2025Buy1,340$4.35$5,800
Kenneth BurdickAug 8, 2025Buy46,511$4.3$200,000
Kenneth BurdickAug 8, 2025Buy45,870$4.36$200,000
Kenneth BurdickAug 8, 2025Buy1,800$4.31$7,800
Ujjwal RamtekkarJun 16, 2025Sell9,519$5.17$49,000
Ujjwal RamtekkarJun 5, 2025Sell16,000$5.94$95,000
Robert BesslerApr 9, 2025Sell2,450$7.01$17,000
Robert BesslerApr 8, 2025Sell7$7$49
Lisa MillerMar 17, 2025Sell18,845$6.9$130,000
Pablo PantaleoniMar 10, 2025Sell15,605$7.64$120,000
Pablo PantaleoniMar 7, 2025Sell19,900$7.29$150,000
Robert BesslerNov 27, 2024Sell37,500$7.54$280,000
Lisa MillerNov 13, 2024Sell10,540$7.45$79,000
Ann VaranakisAug 23, 2024Sell5,269$6.28$33,000

Frequently Asked Questions: Lifestance Health Insider Trading

In the past 90 days, Lifestance Health insiders have made 0 buys and 10 sells. The net selling may indicate insiders are taking profits or reducing exposure.

The most recent sale was by JAMES COULTER who sold 28,281,943 shares on May 12, 2026. View all transactions in the table on this page.

Insider buying is generally a stronger signal than insider selling, since insiders may sell for personal reasons (diversification, taxes) but typically buy only when they believe the stock is undervalued. AltIndex uses insider transaction patterns alongside 25+ other signals in the AI Score.

Burdick Kenneth A has bought the most LFST stock in the last 2 years, with a total value of $500,000.

COULTER JAMES G has sold the most LFST stock in the last 2 years, with a total value of $372M.

The total value of insider transactions for Lifestance Health in the last 2 years is negative, amounting to -$560M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.